<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE ArticleSet PUBLIC "-//NLM//DTD PubMed 2.0//EN" "http://www.ncbi.nlm.nih.gov:80/entrez/query/static/PubMed.dtd">
<ArticleSet>
	<Article>
		<Journal>
			<PublisherName/>
			<JournalTitle>IJOTM</JournalTitle>
			<Issn>2008-6490</Issn>
			<Volume>2</Volume>
			<Issue>3</Issue>
			<PubDate PubStatus="epublish">
				<Year>2011</Year>
				<Month>06</Month>
				<Day>27</Day>
			</PubDate>
		</Journal>
		<ArticleTitle>Half-Saline versus Combined Normal Saline and 1/3–2/3 Intravenous Fluid Therapy in Kidney Transplantation</ArticleTitle>
		<FirstPage>101</FirstPage>
		<LastPage>104</LastPage>
		<Language>EN</Language>
		<AuthorList>
			<Author>
				<FirstName>A</FirstName>
				<LastName>Ghorbani</LastName>
			</Author>
			<Author>
				<FirstName>M</FirstName>
				<LastName>Feli</LastName>
			</Author>
			<Author>
				<FirstName>A</FirstName>
				<LastName>Ehsanpour</LastName>
			</Author>
			<Author>
				<FirstName>H</FirstName>
				<LastName>Shahbazian</LastName>
			</Author>
			<Author>
				<FirstName>F</FirstName>
				<LastName>Hayati</LastName>
			</Author>
			<Author>
				<FirstName>J</FirstName>
				<LastName>Roozbeh</LastName>
				<Affiliation>Shiraz Organ Transplant Center, Namazi Hospital, Shiraz University of Medical Sciences, Shiraz, Iran. roozbehj@hotmail.com</Affiliation>
			</Author>
		</AuthorList>
		<History>
			<PubDate PubStatus="received">
				<Year>2011</Year>
				<Month>06</Month>
				<Day>27</Day>
			</PubDate>
		</History>
		<Abstract>Background: Sufficient intravascular volume should be established for optimal graft function after renal transplantation. However, there is no recommendation for the type of fluid therapy post-operatively. We compared half-saline vs. normal saline and 1/3&amp;ndash;2/3 intravenous fluid replacement after renal transplantation. Methods: We enrolled all patients who underwent kidney transplantation between June 2008 and March 2010 in Golestan Hospital, Ahwaz, southwestern Iran. Patients were randomly divided into two groups using a blinded allocation technique. Group A patients (Case) received half saline, and group B patients (Control) received normal saline and 1/3&amp;ndash;2/3 intravenous fluid. According to our protocol, we replaced as much as 100% of hourly urine output in the first day, followed by 90% and 70% of every 2-hour urine output in the 2nd and 3rd days, respectively. Blood pressure and pulse rate were recorded hourly. Serum sodium, potassium, creatinine and pH were assessed twice a day. Results: There were 34 and 36 eligible patients in the case and control groups, respectively. The mean&amp;plusmn;SD 6-hour urine output in the first 5 days after surgery was 2586&amp;plusmn;725 mL in the control group and 2764&amp;plusmn;758 mL in the case group (p=0.31). The mean&amp;plusmn;SD serum creatinine level at the end of the 5th post-operative day was 1.3&amp;plusmn;0.5 and 1.4&amp;plusmn;0.7 mg/dL in the case and control groups, respectively (p=0.56). Serum creatinine level did not reduce to 1.5 mg/dL or lower in 6 of 36 control subjects and in 4 of 34 cases at the end of the 5th day (p=0.558). The mean&amp;plusmn;SD time to creatinine level &amp;lt;1.5 mg/dL was 1.3&amp;plusmn;1 days in the control group and 1.7&amp;plusmn;0.8 days in the case group (p=0.635). Hyperkalemia occurred in 3 of 36 patients in the control group and in 2 of 34 patients in the case group (p=0.318). The incidence of hyponatremia in the control group was 11% (4 of 36 patients) vs no patients in the case group (p=0.115). Conclusion: Either half-saline or normal saline and 1/3&amp;ndash;2/3 intravenous solution can be safely used as fluid replacement therapy after kidney transplantation.</Abstract>
	</Article>
</ArticleSet>
